Bottom line
BHCFX vs GDOC: the short answer
BHCFX (Baron Health Care Fund) and GDOC (Goldman Sachs Future Health Care Equity ETF) are both mutual funds.
GDOC is cheaper at 0.75% vs 1.1% — a difference of $35 a year per $10,000 invested.
Over one year, BHCFX returned +10.0% vs −1.6% for GDOC (reporting dates differ).
Updated Nov 19, 2026
BHCFX vs GDOC side by side
| BHCFX | GDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Baron Select | Goldman Sachs |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.1% | 0.75% |
| Annual cost per $10k | $110 | $75 |
| 10-yr cost on $10k (prospectus) | $1,340 | $930 |
| Max front load | — | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +10.0% | −1.6% |
| 5-yr return (annualized) | +2.5% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +24.6% | +10.7% |
| Worst quarter | −10.0% | −13.5% |
| Net assets (fund) | $114.1M | $20.1M |
| Number of holdings | 43 | 42 |
| Portfolio turnover | 74% | 46% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BHCFX | GDOC | Difference |
|---|---|---|---|
| 2024 | +1.3% | −1.6% | +2.8% |
| 2023 | +6.2% | +4.9% | +1.3% |
| 2022 | −17.1% | −16.9% | −0.2% |
Source: Fund prospectus bar charts
Holdings overlap
12 of BHCFX's top 25 holdings also appear in GDOC's top 25.
| Holding | BHCFX | GDOC |
|---|---|---|
| Eli Lilly & Co | 13.66% | 13.28% |
| Mettler-Toledo International Inc | 5.60% | 1.59% |
| Johnson & Johnson | 5.56% | 8.07% |
| Argenx SE | 4.23% | 4.07% |
| Thermo Fisher Scientific Inc | 3.91% | 4.52% |
| Roivant Sciences Ltd | 3.88% | 2.39% |
| Edwards Lifesciences Corp | 2.64% | 2.98% |
| Vertex Pharmaceuticals Inc | 2.61% | 1.48% |
| AstraZeneca PLC | 2.49% | 4.84% |
| Merck & Co Inc | 2.48% | 5.94% |
| Guardant Health Inc | 2.17% | 5.34% |
| Intuitive Surgical Inc | 1.74% | 3.90% |
Source: SEC Form N-PORT
BHCFX top 10
- Eli Lilly & Co — 13.66%
- Mettler-Toledo International Inc — 5.60%
- Johnson & Johnson — 5.56%
- Argenx SE — 4.23%
- Thermo Fisher Scientific Inc — 3.91%
- Roivant Sciences Ltd — 3.88%
- Teva Pharmaceutical Industries Ltd — 3.86%
- Welltower Inc — 3.38%
- UnitedHealth Group Inc — 3.28%
- RadNet Inc — 3.24%
GDOC top 10
- Eli Lilly & Company — 13.28%
- Johnson & Johnson — 8.07%
- Merck & Company Inc — 5.94%
- Guardant Health Inc — 5.34%
- Astrazeneca Plc — 4.84%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Intuitive Surgical Inc — 3.90%
- Boston Scientific Corp — 3.78%
- Hoya Corp — 3.53%
FAQ
What is the difference between BHCFX and GDOC?
Which is cheaper, BHCFX or GDOC?
Should I own both BHCFX and GDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.